RIO study team
| Organisation | Organisation Order | Name | Role | Department/Section | ||
|---|---|---|---|---|---|---|
| Rockefeller University | 1 |  | Prof. Michel Nussenzweig | Lead Applicant, Co-Principal Investigator | Laboratory of Molecular Immunology | |
| Rockefeller University | 1 |  | Prof. Marina Caskey | Co-Investigator | Laboratory of Molecular Immunology | |
| Rockefeller University | 1 |  | Dr. Jill Horowitz | Project Lead | Laboratory of Molecular Immunology | |
| Rockefeller University | 1 |  | Adriana Barillas-Batarse | Assistant Director, Finance and Clinical Programs | Laboratory of Molecular Immunology | |
| Imperial College London | 2 |  | Prof. Sarah Fidler | Chief Investigator | Department of Infectious Disease | |
| Imperial College London | 2 |  | Maathini Balachandran | Project Manager | Department of Infectious Disease | |
| Imperial College London | 2 |  | Hanna Box | Operations Manager | Imperial Clinical Trials Unit (ICTU) | |
| Imperial College London | 2 | Dr. Emanuela Falaschetti | Senior Statistician | Imperial Clinical Trials Unit (ICTU) | ||
| Imperial College London | 2 | Stephen Fletcher | Clinical Trial Manager | Imperial Clinical Trials Unit (ICTU) | ||
| Imperial College London | 2 |  | Marta Gielniewska | Clinical Trial Monitor (unblinded) | Imperial Clinical Trials Unit (ICTU) | |
| Imperial College London | 2 | Mariam Habib | Clinical Trial Manager (unblinded) | Imperial Clinical Trials Unit (ICTU) | ||
| Imperial College London | 2 |  | Phil Hepplestone | Laboratory Technician | Department of Infectious Disease | |
| Imperial College London | 2 | Lisa Hurley | Clinical Projects Manager | NIHR Imperial Clinical Research Facility (ICRF) | ||
| Imperial College London | 2 | Ishrat Jahan | Laboratory Technician | Department of Infectious Disease | ||
| Imperial College London | 2 |  | Louise-Rae Cherrill | Trial Statistician | Imperial Clinical Trials Unit (ICTU) | |
| Imperial College London | 2 |  | Dr. Ming Lee | Trial Physician, Clinical Research Fellow | Department of Infectious Disease; St Mary's Hospital |
|
| Imperial College London | 2 | Andrew Lovell | Laboratory Technician | Department of Infectious Disease | ||
| Imperial College London | 2 | Amnah Mirza | Clinical Trials Administrator | Imperial Clinical Trials Unit (ICTU) | ||
| Imperial College London | 2 | Najwa Soussi | Clinical Trial Monitor (blinded) | Imperial Clinical Trials Unit (ICTU) | ||
| Imperial College London | 2 | Katie Topping | Project Administrator | Department of Infectious Disease | ||
| Imperial College London | 2 | Jacquie Ujetz | Laboratory Technician | Department of Infectious Disease | ||
| University of Oxford | 3 |  | Prof. John Frater | Co-Principal Investigator | Nuffield Department of Medicine | |
| University of Oxford | 3 |  | Helen Brown | Research Assistant | Nuffield Department of Medicine | |
| University of Oxford | 3 |  | Mohammed Altaf | Research Associate | Nuffield Department of Medicine | |
| University of Oxford | 3 |  | Nicola Robinson | Research Assistant | Nuffield Department of Medicine | |
| University of Oxford | 3 |  | Peny Zacharopoulou | DPhil Student | Nuffield Department of Medicine | |
| HIV i-Base | 4 |  | Simon Collins | Community Representative | RIO Leadership Group | |
| King's College London | 5 |  | Prof. Frank Post | Professor of HIV Medicine, Consultant Physician in HIV and Infectious Diseases | Chair, RIO Trial Steering Committee (TSC) | |
| King's College London | 5 |  | Prof. Toby Prevost | Lead Statistician | Nightingale-Saunders Chair of Complex Clinical Trials and Statistics | |
| Medical Research Council Clinical Trials Unit at UCL | 6 |  | Prof. Abdel Babiker | Professor of Epidemiology & Medical Statistics | Chair, RIO Independent Data Monitoring Committee (IDMC) | |
| Aarhus University Hospital, Denmark | 7 |  | Prof. Ole Schmeltz Søgaard | Clinical Professor | Principal Investigator, Aarhus University Hospital | |
| Aarhus University Hospital, Denmark | 7 |  | Dr. Jesper Damsgaard Gunst | Clinician Scientist | Co-Investigator, Aarhus University Hospital | |
| UK-CAB | 8 |  | Dr. Ben Cromarty | Community Representative | RIO Trial Steering Committee (TSC) | |
| UK-CAB | 8 |  | Jo Josh | Community Representative | RIO Independent Data Monitoring Committee (IDMC) | |
| University of Cambridge | 9 |  | Prof. Andrew Lever | Professor, Clinician | RIO Independent Data Monitoring Committee (IDMC) | |
| University of Edinburgh | 10 |  | Prof. Clifford Leen | Consultant Physician, Honorary Professor | RIO Trial Steering Committee (TSC) | |
| Erasmus MC Rotterdam | 11 |  | Dr. Casper Rokx | Clinician, Infectious Diseases Specialist | RIO Endpoint Adjudication Committee (EAC) | |
| Ghent University Hospital and Ghent University | 12 |  | Prof. Linos Vandekerckhove | Associate Professor of Infectious Diseases, Specialist Physician | Chair, RIO Endpoint Adjudication Committee (EAC) | |
| Homerton University Hospitals NHS Foundation Trust | 13 |  | Prof. Jane Anderson | Professor and Consultant Physician | RIO Independent Data Monitoring Committee (IDMC) | |
| IrsiCaixa | 14 |  | Dr. Beatriz Mothe | Associate Investigator, HIV Unit | RIO Endpoint Adjudication Committee (EAC) | |
| University of Sussex | 15 |  | Prof. Jaime Vera | Professor in HIV Medicine, Consultant Physician | RIO Trial Steering Committee (TSC) | |
| University College London | 16 |  | Dr. Dimitra Peppa | Consultant HIV Physician, Clinician Scientist | RIO Trial Steering Committee (TSC) |
Funder
The RIO trial is funded by the Bill & Melinda Gates Foundation (Grant ref OPP1210792).
The RIO trial is supported by the NIHR Clinical Research Network (CRN).
